You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Attention Score in Context
| Title |
致死量を超えて内服した市販薬トラベルミン®(ジフェンヒドラミン,ジプロフィリン配合剤)の急性中毒例
|
|---|---|
| Published in |
Journal of Japanese Society for Emergency Medicine, October 2017
|
| DOI | 10.11240/jsem.20.672 |
| Authors |
竹中 信義, 平川 昭彦, 加納 秀記, 津田 雅庸, 武山 直志, 服部 友紀 |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 February 2022.
All research outputs
#16,053,755
of 25,385,509 outputs
Outputs from Journal of Japanese Society for Emergency Medicine
#62
of 185 outputs
Outputs of similar age
#188,202
of 331,227 outputs
Outputs of similar age from Journal of Japanese Society for Emergency Medicine
#2
of 4 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 185 research outputs from this source. They receive a mean Attention Score of 3.4. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 331,227 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.